Bacillus Calmette-Guerin: One third dose versus full dose and one year versus three years of maintenance. Final results of an EORTC GU Cancers Group randomized trial in non muscle invasive bladder cancer

Brausi M. A., Oddens J. R., Sylvester R. J., Bono A., Van de Beek C., Van Andel G., ...More

EUROPEAN UROLOGY SUPPLEMENTS, vol.11, no.1, 2012 (SCI-Expanded)

• Publication Type: Article / Abstract
• Volume: 11 Issue: 1
• Publication Date: 2012
• Journal Name: EUROPEAN UROLOGY SUPPLEMENTS
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
• Marmara University Affiliated: Yes